Editors' ChoiceCancer

Intercepting reversible drug tolerance to improve targeted therapy

See allHide authors and affiliations

Science Translational Medicine  30 Mar 2016:
Vol. 8, Issue 332, pp. 332ec52
DOI: 10.1126/scitranslmed.aaf6467

Article Information

vol. 8 no. 332 332ec52

Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Kris C. Wood
  1. Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA. E-mail: kris.wood{at}duke.edu

Altmetric

Article usage

Article usage: March 2016 to November 2019

AbstractFullPdf
Mar 201601601
Apr 201601730
May 20160190
Jun 20160100
Jul 20160130
Aug 2016070
Sep 20160140
Oct 2016010125
Nov 2016020
Dec 2016050
Jan 2017080
Feb 20170380
Mar 20170520
Apr 20170600
May 20170680
Jun 20170440
Jul 20170390
Aug 20170650
Sep 20170500
Oct 20170560
Nov 20170680
Dec 20170530
Jan 20180380
Feb 20180290
Mar 20180460
Apr 20180350
May 20180380
Jun 20180430
Jul 20180260
Aug 20180250
Sep 20180260
Oct 20180150
Nov 20180312
Dec 20180210
Jan 20190160
Feb 20190240
Mar 20190150
Apr 20190170
May 20190180
Jun 20190200
Jul 20190170
Aug 20190120
Sep 2019090
Oct 20190180
Nov 2019030

Navigate This Article